Categories: News

Visage Joins the AWS Partner Network

The Visage 7 Enterprise Imaging Platform meets AWS guidelines for quality architectural design

SAN DIEGO, June 27, 2022 /PRNewswire/ — Visage Imaging, Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced today it has joined the Amazon Web Services (AWS) Partner Network (APN) as an Advanced Technology Partner. The APN is a global community of partners who leverage AWS to build, market, and sell services for customers.

We are pleased to be classified as an AWS Advanced Technology Partner as the CloudPACS transformation continues.

Becoming an Advanced Technology Partner underscores Visage’s commitment to best practices for security, reliability, and operational excellence – a status that comes in the midst of Imaging’s increasingly accelerating shift to cloud-based technology. The Visage 7 Enterprise Imaging Platform has passed the AWS Foundational Technical Review (FTR), as defined by the AWS Well-Architected Framework.

“Customer-driven innovation, while also supporting industry standards and best practices, has been key to our success,” said Malte Westerhoff, PhD, Visage Co-Founder and Global Chief Technology Officer. “We are pleased to be classified as an AWS Advanced Technology Partner as the CloudPACS (cloudpacs.com™) transformation continues.”

Visage 7 leverages both Amazon Elastic Block Store (EBS) and Amazon Simple Storage Service (Amazon S3) cloud object-based storage to provide ultrafast performance at an affordable cost. Visage 7 already has a reputation for being the fastest viewer available, and with cloud-native storage, performance is approximately 2-3X faster in the cloud as compared to legacy PACS.

Visage 7 Render Servers connect directly to cloud-based storage, enabling the near immediate streaming of all current and prior imaging. Additionally, Visage configures Amazon S3 storage buckets as immutable, providing the ultimate protection for archived imaging studies, as the underlying data cannot be changed or corrupted.

Click here to learn more about Visage 7 on AWS.

About Visage Imaging, Inc.

A global provider of enterprise imaging solutions that enable PACS replacement with local, regional and national scale. The Visage 7 Enterprise Imaging Platform is proven, providing a fast, clinically rich, and highly scalable growth platform deliverable entirely from the cloud or on premise. Visage 7 supports the simplicity of a One Viewer™ philosophy, that enables diagnostic, clinical, specialty, research, and mobile imaging workflows from a singular platform. Visage also offers modular scalability and future-proof flexibility with enterprise workflow (Visage 7 Workflow), vendor-neutral archive (Visage 7 Open Archive) and artificial intelligence (Visage AI Accelerator) solutions, all 100% native. https://visageimaging.com 

About Pro Medicus Limited

Pro Medicus Limited [ASX: PME] is Australia’s leading imaging IT provider. Founded in 1983, the company provides a full range of integrated software products and services to hospital, imaging centers and health care groups worldwide. www.promed.com.au 

Visage, Visage Imaging, Visage Ease Pro, Visage Ease, One Viewer, ANV, CloudPACS.com and Deconstructed PACS are trademarks, registered trademarks and service marks that are licensed by Visage Imaging Inc. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective owners or licensees. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/visage-joins-the-aws-partner-network-301575520.html

SOURCE Visage Imaging, Inc.

Staff

Recent Posts

Revolutionizing Rehabilitation: Introducing Vertonex, an Intelligent Decompression Unit at Physiowell

Presenting a New Innovation in the Field of Spinal Rehabilitation at Physiowell DubaiDUBAI, ARAB EMIRATES…

4 hours ago

Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa

SINGAPORE, June 23, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare…

7 hours ago

Altimmune Presents Data on the Effect of Pemvidutide on Cardioinflammatory Lipids during Oral Presentation at American Diabetes Association’s 84th Annual Scientific Sessions

Pemvidutide elicited significant weight loss and decreases in pro-inflammatory serum lipids associated with atherogenesis and…

10 hours ago

2024 Tang Prize Laureates Announced: Six Global Visionaries to Be Honored in Taiwan This September

TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…

1 day ago